PortfoliosLab logo
KAMN vs. AMAM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between KAMN and AMAM is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

KAMN vs. AMAM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kaman Corporation (KAMN) and Ambrx Biopharma Inc. (AMAM). The values are adjusted to include any dividend payments, if applicable.

KAMN
AMAM

Key characteristics

Fundamentals

Market Cap

KAMN:

$1.31B

AMAM:

$1.77B

EPS

KAMN:

$0.28

AMAM:

$0.42

PE Ratio

KAMN:

164.25

AMAM:

66.67

PS Ratio

KAMN:

1.68

AMAM:

432.96

PB Ratio

KAMN:

1.88

AMAM:

7.31

Returns By Period


KAMN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

AMAM

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

KAMN vs. AMAM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KAMN
The Risk-Adjusted Performance Rank of KAMN is 9090
Overall Rank
The Sharpe Ratio Rank of KAMN is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of KAMN is 9898
Sortino Ratio Rank
The Omega Ratio Rank of KAMN is 9797
Omega Ratio Rank
The Calmar Ratio Rank of KAMN is 8787
Calmar Ratio Rank
The Martin Ratio Rank of KAMN is 9191
Martin Ratio Rank

AMAM
The Risk-Adjusted Performance Rank of AMAM is 9494
Overall Rank
The Sharpe Ratio Rank of AMAM is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of AMAM is 9494
Sortino Ratio Rank
The Omega Ratio Rank of AMAM is 9494
Omega Ratio Rank
The Calmar Ratio Rank of AMAM is 9797
Calmar Ratio Rank
The Martin Ratio Rank of AMAM is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

KAMN vs. AMAM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Kaman Corporation (KAMN) and Ambrx Biopharma Inc. (AMAM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Rolling 12-month Sharpe Ratio
KAMN
AMAM

Dividends

KAMN vs. AMAM - Dividend Comparison

Neither KAMN nor AMAM has paid dividends to shareholders.


2023202220212020201920182017201620152014
KAMN
Kaman Corporation
3.34%3.59%1.85%1.40%1.21%1.43%1.36%1.47%1.76%1.60%
AMAM
Ambrx Biopharma Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

KAMN vs. AMAM - Drawdown Comparison


KAMN
AMAM

Volatility

KAMN vs. AMAM - Volatility Comparison

Kaman Corporation (KAMN) has a higher volatility of 0.41% compared to Ambrx Biopharma Inc. (AMAM) at 0.00%. This indicates that KAMN's price experiences larger fluctuations and is considered to be riskier than AMAM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


KAMN
AMAM

Financials

KAMN vs. AMAM - Financials Comparison

This section allows you to compare key financial metrics between Kaman Corporation and Ambrx Biopharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items